Literature DB >> 229341

Studies on sphingomyelinase activity in cultured cells and leucocytes.

G T Besley.   

Abstract

Using both [3H]ceramide-sphingomyelin and [14C]methyl choline-sphingomyelin as substrate, enzyme activity was determined in skin fibroblasts, cultured amniotic fluid cells and leucocytes. Sphingomyelinase activities of fibroblasts from two patients with Niemann-Pick disease were about 1% of the mean control values (22.9 nmol/h/mg protein and 65.6 nmol/h/mg protein, with [3H]sphingomyelin and [14C]sphingomyelin respectively). Leucocyte sphingomyelinase activity is much lower than that of cultured cells. Optimum sphingomyelinase activity of cultured cells is at pH 5.0 and the apparent Km values are 58 mumol/1 and about 200 mumol/1 for [3H]sphingomyelin and [14C]sphingomyelin respectively. These properties are similar to those for residual sphingomyelinase activity in Niemann-Pick fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 229341     DOI: 10.1007/bf01805712

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  10 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  A method for the determination of sphingomyelinase activity.

Authors:  R E De Rooij; K O Liem; J W Brouwer-Schipper; G G Husmann; G J Hooghwinkel
Journal:  Clin Chim Acta       Date:  1975-02-22       Impact factor: 3.786

3.  Letters: A simple sphingomyelinase determination for Niemann-Pick disease: differential diagnosis of types A, B and C.

Authors:  K Harzer; H U Benz
Journal:  J Neurochem       Date:  1973-10       Impact factor: 5.372

4.  Deficiency of sphingomyelin-cleaving enzyme activity in tissue cultures derived from patients with Niemann-Pick disease.

Authors:  H R Sloan; B W Uhlendorf; J N Kanfer; R O Brady; D S Fredrickson
Journal:  Biochem Biophys Res Commun       Date:  1969-03-10       Impact factor: 3.575

5.  A practical chromogenic procedure for the detection of homozygotes and heterozygous carriers of Niemann-Pick disease.

Authors:  A E Gal; R O Brady; S R Hibbert; P G Pentchev
Journal:  N Engl J Med       Date:  1975-09-25       Impact factor: 91.245

6.  Sphingomyelinases in human tissues. II. Absence of a specific enzyme from liver and brain of Niemann-Pick disease, type C.

Authors:  J W Callahan; M Khalil; M Philippart
Journal:  Pediatr Res       Date:  1975-12       Impact factor: 3.756

7.  Sphingomyelinases in human tissues. III. Expression of Niemann-Pick disease in cultured skin fibroblasts.

Authors:  J W Callahan; M Khalil
Journal:  Pediatr Res       Date:  1975-12       Impact factor: 3.756

8.  Krabbe's globoid cell leucodystrophy. Studies on galactosylceramide beta-galactosidase and non-specific beta-galactosidase of leucocytes, cultured skin fibroblasts, and amniotic fluid cells.

Authors:  G T Besley; A D Bain
Journal:  J Med Genet       Date:  1976-06       Impact factor: 6.318

9.  Diagnosis of gaucher's disease and niemann-pick disease with small samples of venous blood.

Authors:  J P Kampine; R O Brady; J N Kanfer; M Feld; D Shapiro
Journal:  Science       Date:  1967-01-06       Impact factor: 47.728

10.  Sphingomyelinase in normal human spleens and in spleens from subjects with Niemann-Pick disease.

Authors:  P B Schneider; E P Kennedy
Journal:  J Lipid Res       Date:  1967-05       Impact factor: 5.922

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.